Milestone Pharmaceuticals, Inc. (MIST)
1.19
+0.01
(+0.85%)
USD |
NASDAQ |
Aug 27, 16:00
1.20
+0.01
(+0.84%)
Pre-Market: 09:12
Milestone Pharmaceuticals Cash from Operations (Quarterly) : -22.53M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -22.53M |
| March 31, 2026 | -16.05M |
| December 31, 2025 | -12.32M |
| September 30, 2025 | -9.838M |
| June 30, 2025 | -13.03M |
| March 31, 2025 | -13.95M |
| December 31, 2024 | -6.313M |
| September 30, 2024 | -7.038M |
| June 30, 2024 | -5.947M |
| March 31, 2024 | -8.934M |
| December 31, 2023 | -9.222M |
| September 30, 2023 | -12.23M |
| June 30, 2023 | -10.65M |
| March 31, 2023 | -13.90M |
| December 31, 2022 | -11.41M |
| Date | Value |
|---|---|
| September 30, 2022 | -10.98M |
| June 30, 2022 | -13.97M |
| March 31, 2022 | -13.95M |
| December 31, 2021 | -12.29M |
| September 30, 2021 | -9.121M |
| June 30, 2021 | 0.8371M |
| March 31, 2021 | -12.47M |
| December 31, 2020 | -9.679M |
| September 30, 2020 | -8.406M |
| June 30, 2020 | -16.06M |
| March 31, 2020 | -18.08M |
| December 31, 2019 | -16.61M |
| September 30, 2019 | -8.642M |
| June 30, 2019 | -11.43M |
| March 31, 2019 | -14.73M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | -1.759M |
| NervGen Pharma Corp. | -4.086M |
| Clearmind Medicine, Inc. | -1.792M |
| Lexaria Bioscience Corp. | -1.635M |
| Target Group, Inc. (Canada) | -0.2229M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 111.84M |
| Cash from Financing (Quarterly) | 8.652M |
| Free Cash Flow | -61.10M |
| Free Cash Flow Per Share (Quarterly) | -0.1627 |
| Free Cash Flow to Equity (Quarterly) | -27.06M |
| Free Cash Flow to Firm (Quarterly) | -17.85M |
| Free Cash Flow Yield | -43.54% |